Silo Pharma, Inc. (SILO) stock
SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.84−0.07 (-3.66%)
Close on Nov 13, 2026Market cap $2.92MP/E –Yield –
Silo Pharma operating margin
Operating margin is operating income as a percentage of revenue.
Silo Pharma's operating margin for the twelve months ending Sep 30, 2026 was -12534.1%. For fiscal 2025 it was -5937.0%, against -6526.4% the year before. The highest annual figure on record is -2293.4% in fiscal 2019.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -5937.0% | +589.5 |
| FY2024 | Dec 31, 2024 | -6526.4% | −1179.0 |
| FY2023 | Dec 31, 2023 | -5347.4% | −316.1 |
| FY2022 | Dec 31, 2022 | -5031.3% | +348.9 |
| FY2020 | Dec 31, 2020 | -5380.2% | −3086.8 |
| FY2019 | Dec 31, 2019 | -2293.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -8846.4% | −2776.8 |
| Q4 FY2025 | Dec 31, 2025 | -4363.3% | +5696.4 |
| Q3 FY2025 | Sep 30, 2025 | -6388.2% | −784.5 |
| Q2 FY2025 | Jun 30, 2025 | -6926.8% | −471.0 |
| Q1 FY2025 | Mar 31, 2025 | -6069.7% | −748.1 |
| Q4 FY2024 | Dec 31, 2024 | -10059.6% | −867.6 |
| Q3 FY2024 | Sep 30, 2024 | -5603.6% | −337.9 |
| Q4 FY2023 | Dec 31, 2023 | -6455.8% | −3713.6 |
| Q1 FY2023 | Jun 30, 2023 | -5321.5% | −4679.9 |
| Q4 FY2022 | Dec 31, 2022 | -9192.0% | −7292.2 |
| Q3 FY2022 | Sep 30, 2022 | -5265.8% | −2592.3 |
| Q2 FY2022 | Jun 30, 2022 | -2742.2% | +689.7 |
| Q2 FY2021 | Jun 30, 2021 | -641.6% | +44335.5 |
| Q1 FY2021 | Mar 31, 2021 | -1899.8% | +52303.6 |
| Q4 FY2020 | Dec 31, 2020 | -2673.4% | −1870.8 |
| Q3 FY2020 | Sep 30, 2020 | -3431.9% | +87055.7 |
| Q2 FY2020 | Jun 30, 2020 | -44977.1% | – |
| Q1 FY2020 | Mar 31, 2020 | -54203.4% | – |
| Q4 FY2019 | Dec 31, 2019 | -802.6% | – |
| Q3 FY2019 | Sep 30, 2019 | -90487.7% | – |
See a number that looks wrong?